Bloomberg Intelligence cover image

Novo Nordisk Gets US Approval for Wegovy Obesity Pill 

Bloomberg Intelligence

00:00

Wegovy pill efficacy and market positioning

Lars explains pill efficacy (around 17%), cardiovascular benefits, and direct competition with injectable treatments.

Play episode from 02:48
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app